- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.05. | Adagio Medical Holdings, Inc. GAAP EPS of -$0.51 | - | Seeking Alpha | ||
| ADAGIO MEDICAL Aktie jetzt für 0€ handeln | |||||
| 17.04. | Why Adagio Medical Holdings (ADGM) Stock Is Skyrocketing | 6 | Benzinga.com | ||
| 17.04. | Adagio Medical wins FDA breakthrough nod for cryoablation tech | 3 | MassDevice | ||
| 02.04. | Adagio Medical Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 31.03. | Adagio Medical Holdings reports Q4 results | 2 | Seeking Alpha | ||
| 27.03. | Adagio Medical Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 27.03. | Adagio Medical Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 17.03. | Adagio Medical Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 28.02. | Cryoablation developer Adagio Medical lays off staff, refocuses on US study | 2 | FierceBiotech | ||
| 28.02. | Adagio Medical to restructure, reduce workforce | 2 | MassDevice | ||
| 28.02. | Adagio Medical Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.02. | Adagio Medical Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.02. | Adagio Medical Holdings, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 14.01. | Adagio Medical Holdings, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 06.01. | Adagio Medical Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.24 | Adagio Medical Reports Third Quarter 2024 Results | 163 | Business Wire | LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the "Company" or "Adagio"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias... ► Artikel lesen | |
| 31.07.24 | Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias | 223 | Business Wire | LAGUNA HILLS, Calif. & NEW YORK--(BUSINESS WIRE)--Adagio Medical, Inc. ("Adagio Medical"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, announced... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 47,780 | -1,12 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
| DRAEGERWERK | 66,20 | +0,15 % | Dräger-Aktie legt um 0,15 Prozent zu (67,10 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Dräger zur Stunde im Plus. Der jüngste Kurs betrug 67,10 Euro. Das Wertpapier von Dräger verzeichnet aktuell ein Kursplus von 0,15 Prozent. Es... ► Artikel lesen | |
| THERMO FISHER | 361,40 | -0,29 % | Here's What to Expect From Thermo Fisher Scientific's Next Earnings Report | ||
| STRATEC | 27,050 | 0,00 % | EQS-News: STRATEC SE: Hauptversammlung beschliesst Dividendenausschüttung in Höhe von 0,60 € je Aktie | EQS-News: STRATEC SE
/ Schlagwort(e): Hauptversammlung
STRATEC-HAUPTVERSAMMLUNG BESCHLIESST DIVIDENDENAUSSCHÜTTUNG IN HÖHE VON 0,60 € JE AKTIE
27.06.2025... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,100 | +8,70 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| FAMICORD | 4,320 | 0,00 % | Original-Research: FamiCord AG (von Montega AG): Kaufen | Original-Research: FamiCord AG - von Montega AG 06.06.2025 / 17:08 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den Inhalt der Mitteilung... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,702 | -0,99 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
| PING AN HEALTHCARE | 0,976 | +0,02 % | PA GOODDOCTOR (01833): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2025 | ||
| DENTSPLY SIRONA | 14,150 | +0,75 % | Dividendenbekanntmachungen (27.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,6216 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1795 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
| ORGANON | 8,552 | -0,60 % | Karolinska Development AB (publ): Karolinska Development receives update from Organon concerning OG-6219 | ||
| CO-DIAGNOSTICS | 0,238 | -3,25 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| SONIC HEALTHCARE | 14,700 | -0,34 % | SONIC HEALTHCARE LIMITED: Settlement of the Acquisition of the LADR Laboratory Group | ||
| CYTOSORBENTS | 0,826 | -3,05 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| VERU | 0,503 | +1,39 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen |
ADAGIO MEDICAL HOLDINGS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,520 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADAGIO MEDICAL HOLDINGS INC finden Sie auf Wallstreet Online.